Prospective effects of traumatic event re‐exposure and post‐traumatic stress disorder in syringe exchange participants
Links to Fileshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518559/
MetadataShow full item record
Type of Work13 pages
journal articles postprints
Citation of Original PublicationPeirce, J. M., Brooner, R. K., Kolodner, K., Schacht, R. L., & Kidorf, M. S. (2013). Prospective effects of traumatic event re-exposure and post-traumatic stress disorder in syringe exchange participants. Addiction (Abingdon, England), 108(1), 146–153. https://doi.org/10.1111/j.1360-0443.2012.04003.x
RightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
This is the peer reviewed version of the following article: Peirce, J. M., Brooner, R. K., Kolodner, K., Schacht, R. L., & Kidorf, M. S. (2013). Prospective effects of traumatic event re-exposure and post-traumatic stress disorder in syringe exchange participants. Addiction (Abingdon, England), 108(1), 146–153. https://doi.org/10.1111/j.1360-0443.2012.04003.x, which has been published in final form at https://doi.org/10.1111/j.1360-0443.2012.04003.x. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. All other rights are reserved.
Aim Determine the effect of traumatic event re-exposure and PTSD symptom severity on proximal drug use and drug abuse treatment-seeking in syringe exchange participants. Design Prospective longitudinal 16-month cohort study of new syringe exchange registrants enrolled in a parent study of methods to improve treatment engagement. Setting Data were collected in a research van next to mobile syringe exchange distribution sites in Baltimore, Maryland. Participants Male and female (N = 162) injecting drug users (IDUs) registered for syringe exchange. Measurements Traumatic event re-exposure was identified each month with the Traumatic Life Events Questionnaire. PTSD symptoms were measured with the Modified PTSD Symptom Scale-Revised, given every four months. Outcome measures collected monthly were days of drug use (heroin, cocaine) and drug abuse treatment-seeking behavior (interest, calls to obtain treatment, treatment participation). Findings Each traumatic event re-exposure was associated with about 1 more day of cocaine use after accounting for the previous month’s cocaine use [same month adjusted B(SE) = 1.16 (0.34); one month later: .99 (0.34)], while PTSD symptoms had no effect. Traumatic event re-exposure increased interest in drug abuse treatment [same month adjusted odds ratios with 95% confidence intervals = 1.34 (1.11–1.63)] and calling to obtain treatment [same month 1.58 (1.24–2.01); one month later 1.34 (1.03–1.75)]. Each 10% increase in PTSD symptom severity was associated with persistent increased interest in treatment [same month 1.25 (1.10–1.42); one month later 1.16 (1.02–1.32); two months later 1.15 (1.02–1.30)] and calling to obtain treatment [same month 1.16 (1.02–1.32)]. Neither traumatic events nor PTSD symptoms were associated with participants receiving treatment. Conclusions Becoming exposed again to traumatic events among injecting drug users is associated with an increase in cocaine use up to one month later, but drug use is not related to post-traumatic stress disorder symptoms. Both traumatic event re-exposure and posttraumatic stress disorder symptoms predict drug abuse treatment-seeking behavior for up to two months.